Cargando…

Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy

Detalles Bibliográficos
Autores principales:	Yin, Lin, Li, Na, Jia, Weihua, Wang, Nuoqi, Liang, Meidai, Shang, Jiamin, Qiang, Guifen, Du, Guanhua, Yang, Xiuying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126497/ https://www.ncbi.nlm.nih.gov/pubmed/35605093 http://dx.doi.org/10.1002/ctm2.879

Ejemplares similares

Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor
por: Li, Na, et al.
Publicado: (2022)

The Positive Impact of Vitamin D on Glucocorticoid-Dependent Skeletal Muscle Atrophy
por: Karnia, Mateusz Jakub, et al.
Publicado: (2021)

Muscle Atrophy in Response to Cytotoxic Chemotherapy Is Dependent on Intact Glucocorticoid Signaling in Skeletal Muscle
por: Braun, Theodore P., et al.
Publicado: (2014)

eIF3f: A central regulator of the antagonism atrophy/hypertrophy in skeletal muscle()
por: Sanchez, Anthony M.J., et al.
Publicado: (2013)

Potential Therapeutic Strategies for Skeletal Muscle Atrophy
por: Huang, Li, et al.
Publicado: (2022)

Urotensin II Inhibits Skeletal Muscle Glucose Transport Signaling Pathways via the NADPH Oxidase Pathway
por: Wang, Hong-Xia, et al.
Publicado: (2013)

Glucocorticoids increase skeletal muscle NF‐κB inducing kinase (NIK): links to muscle atrophy
por: Fry, Christopher S., et al.
Publicado: (2016)

Nutrients against Glucocorticoid-Induced Muscle Atrophy
por: Lee, Min-Kyeong, et al.
Publicado: (2022)

Metabolic Remodeling in Skeletal Muscle Atrophy as a Therapeutic Target
por: Renzini, Alessandra, et al.
Publicado: (2021)

Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2018)

Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008)

Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
por: Cid‐Díaz, Tania, et al.
Publicado: (2021)

Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)

Inflammation: Roles in Skeletal Muscle Atrophy
por: Ji, Yanan, et al.
Publicado: (2022)

Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy
por: Andres-Mateos, Eva, et al.
Publicado: (2013)

BST Stimulation Induces Atrophy and Changes in Aerobic Energy Metabolism in Rat Skeletal Muscles—The Biphasic Action of Endogenous Glucocorticoids
por: Karnia, Mateusz Jakub, et al.
Publicado: (2020)

Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells
por: Iglewski, Myriam, et al.
Publicado: (2010)

Skeletal muscle antagonizes antiviral CD8(+) T cell exhaustion
por: Wu, Jingxia, et al.
Publicado: (2020)

Mitochondrial dysfunction: roles in skeletal muscle atrophy
por: Chen, Xin, et al.
Publicado: (2023)

Ubiquitin-proteasome pathway in skeletal muscle atrophy
por: Pang, XiangSheng, et al.
Publicado: (2023)

Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells
por: Park, Sung Lyea, et al.
Publicado: (2013)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

Potential Therapeutic Role of L-Carnitine in Skeletal Muscle Oxidative Stress and Atrophy Conditions
por: Montesano, Anna, et al.
Publicado: (2015)

Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy
por: Sepulveda, Patricio V., et al.
Publicado: (2015)

Metronidazole Causes Skeletal Muscle Atrophy and Modulates Muscle Chronometabolism
por: Manickam, Ravikumar, et al.
Publicado: (2018)

GLUCOCORTICOID-INDUCED HYPERTENSION AND CARDIAC INJURY: EFFECTS OF MINERALOCORTICOID AND GLUCOCORTICOID RECEPTOR ANTAGONISM
por: HATTORI, TAKUYA, et al.
Publicado: (2013)

Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines
por: Geyik, Sırma, et al.
Publicado: (2016)

Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGF/PI3K/AKT signaling
por: Mishra, Sneha, et al.
Publicado: (2022)

Molecular and cellular mechanisms of skeletal muscle atrophy: an update
por: Fanzani, Alessandro, et al.
Publicado: (2012)

Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy
por: Miller, Spencer G., et al.
Publicado: (2019)

Ubiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control
por: Peris-Moreno, Dulce, et al.
Publicado: (2021)

Prevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions
por: Jun, Lauren, et al.
Publicado: (2023)

Quantitative assessment of muscle mass and gene expression analysis in dogs with glucocorticoid-induced muscle atrophy
por: YOSHIDA, Kei, et al.
Publicado: (2022)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014)

Urotensin-II: More Than a Mediator for Kidney
por: Balat, Ayşe, et al.
Publicado: (2012)

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
por: Kim, Young-Ae, et al.
Publicado: (2016)

Role of Urotensin-II in Saphenous Vein Graft Disease
por: Tüysüz, Mehmet Erin, et al.
Publicado: (2020)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice
por: Chen, Xi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mps9ikpe39f6aakcpkvtivl2k8